Solutions
Advisory Services
Clinical Development
- Generics Development
- Clinical Operations
- Clinical Data Sciences
- Medical and Safety Services
- RWD & RWE Services
Post Marketing
- Safety Services
- Post marketing Studies
- Regulatory Affairs
Diversity, equity, and inclusion (DEI) are no longer optional ideals for organizations. They are essential drivers of innovation, employee engagement, and sustainable growth. While many companies have made strides toward ensuring inclusive workplaces, the gap between intention and implementation remains significant. Addressing this gap requires not...
Thailand’s pharmaceutical and clinical trials industry is undergoing a transformative phase, positioning itself as a critical player in the global healthcare ecosystem. As the demand for innovative solutions grows, regulatory complexities, market dynamics, and therapeutic advancements converge to create a challenging yet promising environmen...
As a trusted diabetes CRO, we’re honoured to recognize World Diabetes Day and this year’s theme, 'Breaking Barriers and Bridging Gaps.' This theme calls on us to confront the critical challenges and inequalities that prevent effective diabetes care. Millions around the world struggle to access the healthcare, education, and resources ...
In a world where healthcare increasingly relies on data-driven insights, real-world evidence consulting (RWE) consulting is emerging as a pivotal tool, particularly in the pharmaceutical industry. RWE provides insights into the broader impact of medical interventions beyond the controlled environment of traditional clinical trials. Real world data ...
October is Breast Cancer Awareness Month, an annual campaign dedicated to raising awareness and reflecting on the progress in breast cancer research, prevention, and treatment. Breast cancer remains the most common cancer worldwide, with approximately 2.3 million new cases diagnosed each year. Advances in early detection and treatment are transform...
First-in-human (FIH) clinical trials mark a significant turning point in drug development, where a new therapy moves from the lab to being tested in humans for the very first time. An FIH study is not just a milestone in scientific discovery; it represents an intricate balance between innovation and patient safety. At Navitas Life Sciences, we are ...
At Navitas Life Sciences, we understand the immense impact cardiovascular diseases have on global health, making advancements in treatment essential. Cardiovascular clinical trials, including some landmark cardiology trials, are vital for testing innovative therapies and interventions that can improve patient outcomes and save lives. These trials a...
Alzheimer’s disease stands as one of the most challenging medical puzzles of our time, affecting millions of people globally. As a progressive neurodegenerative disorder, Alzheimer's leads to a steady decline in cognitive function, ultimately depriving individuals of their memory, reasoning, and autonomy. The pathological mechanisms driving ...
Navitas Life Sciences offers comprehensive regulatory services that empower pharmaceutical, biotechnology, and medical device companies to meet stringent global standards while accelerating time-to-market. By leveraging cutting-edge technologies, such as AI in regulatory compliance and reporting, the company is transforming the way organizations ma...
At Navitas Life Sciences, we pride ourselves on being at the forefront of providing comprehensive medical and regulatory consulting services that help our clients achieve operational excellence, ensure compliance, and act as a catalyst for increased competitiveness, efficiency and speed to market. As one of the top medical and regulatory consulting...